Company Overview
Founded in 2013, Beijing Qianzhao Xinye Biotechnology Co., Ltd.focuses on the research and development of new technologies in the life science field and the transformation of new technologies in the auxiliary treatment field. Its business covers many countries, and is in the leading position in the life science field and the auxiliary treatment field. In 2017, Qianzhao Information Industry Australia Branch was established.
The company adopts an international standard management system to promote its various management work, and has successively obtained ISO9001 quality management system certification and national high-tech enterprise certification.
The company's main business includes health food registration and filing, new food raw material registration and filing, special food registration and filing, and can provide scientific research services such as primary cell culture, molecular biology testing, cell biology testing, genomics services, pathology testing, antibody drug development and customization.
Corporate partners
The company's scientific research consultants include several academicians of the CAE Member, the chief scientist of the National Planned Vaccine Program, members of the National Pharmacopoeia Committee, and have maintained long-term and good cooperative relations with many well-known high-end scientific research institutions in China. The scientific research results have been published in journals such as Small. From basic research to application research, a full series of product production lines have been established through independent research and development, cooperation with scientific research institutions, and employment of domestic and foreign industry experts.
Core concept of the company
Adhering to the value concept of honesty and trustworthiness, pragmatic innovation, harmony and win-win, we will build a first-class product, technology and service provider in the field of life science and auxiliary medical care.
Company development direction
Based on the frontier field of biological science, after years of independent research and development and joint technology introduction at home and abroad, it has taken the lead in realizing the large-scale application of biopharmaceutical technology in the field of new health products. It is a high-tech enterprise applying genetic engineering technology, microbial transformation technology and cross platform biotechnology.
Company achievements
It has domestic top R&D test platform - molecular test platform - protein test platform - cell test platform - microbial test platform - animal test platform.
In the direction of research and development of new health care products, the team applied modern pharmaceutical technology to screen, extract and purify more than 20 kinds of traditional Chinese medicine formulas from hundreds of thousands of traditional Chinese medicines, which have the functions of promoting the proliferation of hematopoietic stem cells, inhibiting tumor occurrence, and improving intestinal microcirculation, and supplemented with a variety of plant extracts beneficial to intestinal bacteria colonization to produce intestinal bacteria colonization, He has won the first prize of the "Second China Jinan New Energy International High level Talent Innovation and Entrepreneurship Competition" in the field of biomedicine, as well as the "5150" recruitment plan of Jinan in 2019.
Targeted product R&D direction, specializing in the production of antigens, antibodies and enzymes, our company's COVID-19 quantitative kit can not only qualitatively detect, but also quantitatively detect N antibodies, which is very useful for the evaluation of antibodies.
